BACKGROUND: Hematopoietic stem cell transplantation is a demanding cancer treatment associated with enduring physical and psychological complications. Survivors' well-being may be further compromised by exposure to chronic stressors common to this population, including difficulties arising from costly medical care, changes in employment status, and health insurance coverage. Thus, we hypothesized that financial, employment, and insurance stressors (collectively referred to as economic survivorship stressors) would be associated with poorer health-related quality of life (HRQOL) among hematopoietic stem cell transplantation survivors. METHODS: Survivors (n = 181; M = 640 days post-transplant) completed the measures of study variables through mailed questionnaires and telephone interviews. Hierarchical regression analyses were conducted to test the hypothesized associations between economic survivorship stressors and HRQOL, and to examine whether social and situational factors interact with survivors' stress perceptions to predict HRQOL. RESULTS: Greater financial and employment stress were associated with poorer functioning across multiple HRQOL domains, even after controlling for the effects of possible confounding sociodemographic and medical variables. Insurance stress was not associated with HRQOL. Some associations were moderated by situational factors including timing of the current financial crisis and portion of the transplant paid for by health insurance. CONCLUSIONS: Hematopoietic stem cell transplantation survivors can face serious economic challenges during recovery. Results suggest the value of viewing these challenges as chronic stressors capable of reducing survivors' mental and physical well-being. Identifying resources and skills that help survivors cope with these demands is an important goal for clinicians and researchers.
BACKGROUND: Hematopoietic stem cell transplantation is a demanding cancer treatment associated with enduring physical and psychological complications. Survivors' well-being may be further compromised by exposure to chronic stressors common to this population, including difficulties arising from costly medical care, changes in employment status, and health insurance coverage. Thus, we hypothesized that financial, employment, and insurance stressors (collectively referred to as economic survivorship stressors) would be associated with poorer health-related quality of life (HRQOL) among hematopoietic stem cell transplantation survivors. METHODS: Survivors (n = 181; M = 640 days post-transplant) completed the measures of study variables through mailed questionnaires and telephone interviews. Hierarchical regression analyses were conducted to test the hypothesized associations between economic survivorship stressors and HRQOL, and to examine whether social and situational factors interact with survivors' stress perceptions to predict HRQOL. RESULTS: Greater financial and employment stress were associated with poorer functioning across multiple HRQOL domains, even after controlling for the effects of possible confounding sociodemographic and medical variables. Insurance stress was not associated with HRQOL. Some associations were moderated by situational factors including timing of the current financial crisis and portion of the transplant paid for by health insurance. CONCLUSIONS: Hematopoietic stem cell transplantation survivors can face serious economic challenges during recovery. Results suggest the value of viewing these challenges as chronic stressors capable of reducing survivors' mental and physical well-being. Identifying resources and skills that help survivors cope with these demands is an important goal for clinicians and researchers.
Authors: Paul B Jacobsen; David Shibata; Erin M Siegel; Ji-Hyun Lee; William J Fulp; Carlos Alemany; Guillermo Abesada-Terk; Richard Brown; Thomas Cartwright; Douglas Faig; George Kim; Richard Levine; Merry-Jennifer Markham; Fred Schreiber; Philip Sharp; Mokenge Malafa Journal: Psychooncology Date: 2010-09-27 Impact factor: 3.894
Authors: S J Lee; D Fairclough; S K Parsons; R J Soiffer; D C Fisher; R L Schlossman; J H Antin; J C Weeks Journal: J Clin Oncol Date: 2001-01-01 Impact factor: 44.544
Authors: Theresa A Hastert; Jaclyn M Kyko; Amanda R Reed; Felicity W K Harper; Jennifer L Beebe-Dimmer; Tara E Baird; Ann G Schwartz Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-05-06 Impact factor: 4.254
Authors: J Winterling; E Johansson; A Wennman-Larsen; L-M Petersson; P Ljungman; K Alexanderson Journal: Bone Marrow Transplant Date: 2014-03-10 Impact factor: 5.483
Authors: Randy Albelda; Emily Wiemers; Theresa Hahn; Nandita Khera; Diana Y Salas Coronado; Gregory A Abel Journal: Qual Life Res Date: 2019-04-27 Impact factor: 4.147
Authors: Eden R Brauer; Huibrie C Pieters; Patricia A Ganz; Wendy Landier; Carol Pavlish; MarySue V Heilemann Journal: J Adolesc Young Adult Oncol Date: 2017-06-08 Impact factor: 2.223
Authors: Betty K Hamilton; Lisa Rybicki; Sally Arai; Mukta Arora; Corey S Cutler; Mary E D Flowers; Madan Jagasia; Paul J Martin; Jeanne Palmer; Joseph Pidala; Navneet S Majhail; Stephanie J Lee; Nandita Khera Journal: Biol Blood Marrow Transplant Date: 2017-10-12 Impact factor: 5.742
Authors: Salene M W Jones; Jean C Yi; Heather S L Jim; Alison W Loren; Navneet S Majhail; Joseph Uberti; Victoria Whalen; Wendy M Leisenring; Mary E D Flowers; Stephanie J Lee; Karen L Syrjala Journal: Support Care Cancer Date: 2020-01-08 Impact factor: 3.603
Authors: Margaret Bevans; Areej El-Jawahri; D Kathryn Tierney; Lori Wiener; William A Wood; Flora Hoodin; Erin E Kent; Paul B Jacobsen; Stephanie J Lee; Matthew M Hsieh; Ellen M Denzen; Karen L Syrjala Journal: Biol Blood Marrow Transplant Date: 2016-09-19 Impact factor: 5.742
Authors: Gregory A Abel; Randy Albelda; Nandita Khera; Theresa Hahn; Diana Y Salas Coronado; Oreofe O Odejide; Kira Bona; Reginald Tucker-Seeley; Robert Soiffer Journal: Biol Blood Marrow Transplant Date: 2016-05-13 Impact factor: 5.742